Personalized medicine. Closing the gap between knowledge and clinical practice

被引:39
|
作者
Anaya, Juan-Manuel [1 ]
Duarte-Rey, Carolina [1 ]
Sarmiento-Monroy, Juan C. [1 ]
Bardey, David [2 ,3 ]
Castiblanco, John [1 ,4 ]
Rojas-Villarraga, Adriana [1 ]
机构
[1] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Carrera 26 63B-51, Bogota 111221, Colombia
[2] Univ Los Andes, Fac Econ Cede, Bogota, Colombia
[3] Toulouse Sch Econ, Toulouse, France
[4] Univ Rosario, Doctoral Program Biomed Sci, Bogota 111221, Colombia
关键词
Precision medicine; Pharmacogenomics; Autoimmune ecology; Rheumatoid arthritis; Type; 1; diabetes; Developing countries; PRIMARY BILIARY-CIRRHOSIS; ANTITUMOR NECROSIS FACTOR; TYPE-1; DIABETES-MELLITUS; LATIN-AMERICAN PATIENTS; RHEUMATOID-ARTHRITIS; VITAMIN-D; AUTOIMMUNE-DISEASES; PRIMARY PREVENTION; ADALIMUMAB TREATMENT; BRITISH-SOCIETY;
D O I
10.1016/j.autrev.2016.06.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Personalized medicine encompasses a broad and evolving field informed by a patient distinctive information and biomarker profile. Although terminology is evolving and some semantic interpretations exist (e.g., personalized, individualized, precision), in a broad sense personalized medicine can be coined as: "To practice medicine as it once used to be in the past using the current biotechnological tools." A humanized approach to personalized medicine would offer the possibility of exploiting systems biology and its concept of P5 medicine, where predictive factors for developing a disease should be examined within populations in order to establish preventive measures on at-risk individuals, for whom healthcare should be personalized and participatory. Herein, the process of personalized medicine is presented together with the options that can be offered in health care systems with limited resources for diseases like rheumatoid arthritis and type 1 diabetes. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:833 / 842
页数:10
相关论文
共 50 条
  • [1] Personalized Medicine: Bridging the Gap between Genetics and Clinical Practice
    Imran, Mohd
    Abida
    Ben Khaled, Hayet
    Alanazi, Abdulrahman Thamer
    Alanazi, Mohammed Amer
    Alshammari, Khalid Adnan
    Alenezi, Mashari Abdullah
    Skhawat, Hina
    Ali, Muhammad Skhawat
    Siddique, Muhammad Irfan
    ASIAN JOURNAL OF PHARMACEUTICS, 2024, 18 (04) : 1073 - 1081
  • [2] Metabolic profiling in personalized medicine: bridging the gap between knowledge and clinical practice in Type 2 diabetes
    Zolotov, Sagit
    Ben Yosef, Dafna
    Rishe, Naphtali D.
    Yesha, Yelena
    Karnieli, Eddy
    PERSONALIZED MEDICINE, 2011, 8 (04) : 445 - 456
  • [3] Chronic kidney disease in pediatrics: Closing the gap between knowledge and clinical practice
    Ferraris, Veronica
    Ferraris, Jorge R.
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2025,
  • [4] Closing the gap between evidence and practice: Utilizing knowledge translation in the clinical area
    Mustard, Mary
    Harrington, Heather
    Bjerkseth, Brenda
    Metcalfe, Kelly
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 323C - 323C
  • [5] Closing the Gap between NLP Research and Clinical Practice
    Chapman, W. W.
    METHODS OF INFORMATION IN MEDICINE, 2010, 49 (04) : 317 - 319
  • [6] Closing the Personalized Medicine Information Gap: HER2 Test Documentation Practice
    Ferrusi, Ilia L.
    Earle, Craig C.
    Trudeau, Maureen
    Leighl, Natasha B.
    Pullenayegum, Eleanor
    Khong, Hoa
    Hoch, Jeffrey S.
    Marshall, Deborah A.
    AMERICAN JOURNAL OF MANAGED CARE, 2013, 19 (01): : 17 - 26
  • [7] From knowledge to clinical practice: the introduction of evidence-based medicine.
    Fieschi, M
    Giorgi, R
    Gouvernet, J
    Degoulet, P
    REVUE DE MEDECINE INTERNE, 2000, 21 (01): : 105 - 109
  • [8] Closing the Gap Between Clinical Trials and Practice A Global Imperative
    Gaziano, Thomas A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (20) : 2392 - 2394
  • [9] CLOSING GAP BETWEEN MEDICINE AND PSYCHIATRY
    不详
    AMERICAN JOURNAL OF PSYCHIATRY, 1966, 122 (10): : 1198 - &
  • [10] The feasibility of personalized medicine.
    Stuerzebecher, S
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (06): : 701 - 701